REFERENCES

• BurkeMJ.PreskornSH.Short term treatment of mood disorders with standard antidepressants. In: Bloom FE, Kupfer DJ, ed. Psychopharmacology: the fourth Generation of Progress. New York, NY: Raven Press;199510531065
   Google Scholar
• DrevetsWC.Neuroimaging studies of mood disorders. Biol Psychiatry.200015;48813829
   Web of Science ®Google Scholar
• BolwigTG.MadsenTM.Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatrica Scandinavica.2007115130135
   Web of Science ®Google Scholar
• DumanRS.Synaptic plasticity and mood disorders. Mol Psychiatry.20027(suppl 1)S29S3411986993
   PubMed Web of Science ®Google Scholar
• DumanRS.MonteggiaLM.A neurotrophic model for stress-related mood disorders. Biol Psychiatry.2006591116112716631126
   PubMed Web of Science ®Google Scholar
• SchuleC.BaghaiTC.RupprechtR.[New insights into the pathogenesis and pathophysiology of depression]. Nervenarzt.200778(suppl 353154717960353
   PubMed Web of Science ®Google Scholar
• Pandi-PerumalSR3.TrakhtI.SrinivasanV.et al.Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol.20088533535318571301
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC: American Psychiatric Association;2000
   Google Scholar
• World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization;1992
   Google Scholar
• World Health Organization. Depression. WHO report on mental health. 2005. Available at: URL: http://www.who.int/inental health/management/depression/definition/en/.
   Google Scholar
• BauerM.WhybrowPC.AngstJ.VersianiM.MöllerH-J.WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of unipolar depressive disorder. Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry.20023443
   Google Scholar
• ShorterE.The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand.2007115513
   Web of Science ®Google Scholar
• FinkM.TaylorMA.Resurrecting melancholia. Acta Psychiatr Scand.20071151420
   Web of Science ®Google Scholar
• ParkerG.Defining melancholia: the primacy of psychomotor disturbance.Acta Psychiatr Scand.2007115213017201862
   PubMed Web of Science ®Google Scholar
• KhanAY.CarrithersJ.PreskornSH.et al.Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry.200618919816754414
   PubMedGoogle Scholar
• StewartJW.McGrathPJ.QuitkinFM.KleinDF.Atypical depression: current status and relevance to melancholia. Acta Psychiatr Scand.20071155871
   Web of Science ®Google Scholar
• HenkelV.MerglR.AllgaierAK.KohnenR.MöllerHJ.HegerlU.Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res.2006 301418910116321446
   PubMed Web of Science ®Google Scholar
• HamiltonM.A rating scale for depression. J Neurol Neurosurg Psychiatry.196023566214399272
   PubMed Web of Science ®Google Scholar
• SteinmeyerEM.MollerHJ.Facet theoretic analysis of the Hamilton-D scale. J Affect Disord.19922553611385599
   PubMed Web of Science ®Google Scholar
• BechP.AllerupP.GramLF.et al.The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand.1981632902997015793
   PubMed Web of Science ®Google Scholar
• LecrubierY.BechP.The Ham D is more homogenous and as sensitive as the Ham D.Eur Psychiatry.20072225225517344030
   PubMed Web of Science ®Google Scholar
• CoryellW.The facets of melancholia. Acta Psychiatr Scand.20071153136
   Web of Science ®Google Scholar
• BrownWA.Treatment response in melancholia. Acta Psychiatr Scand.2007115125129
   Web of Science ®Google Scholar
• National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy W , Bonato RR, eds. Manual for the EDCEU Assessment Battery 2 Rev. Chevy Chase, MD: NIM;197612-112-6
   Google Scholar
• MontgomerySA.AsbergM.A new depression scale designed to be sensitive to change. Br J Psychiatry.1979134382389444788
   PubMed Web of Science ®Google Scholar
• MontgomerySA.KasperS.Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine.Int Clin Psychopharmacol.20072228329117690597
   PubMed Web of Science ®Google Scholar
• AzorinJM.LlorcaPM.DespiegelN.VerpillatP.[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Encephale.20043015816615107719
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Available at: www nice org uk/pdf/CG023quickrefguide pdf. 2004;Clinical Guideline 23.
   Google Scholar
• KasperS.Hypericum perforatum-a review of clinical studies. Pharmacopsychiatry.200134(suppl 1)S51S5511518077
   PubMed Web of Science ®Google Scholar
• LaakmannG.SchuleC.BaghaiT.KieserM.St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry.199831(suppl 1)54599684948
   PubMed Web of Science ®Google Scholar
• GuptaRK.MollerHJ.St. John's Wort. An option for the primary care treatment of depressive patients? Eur Arch Psychiatry Clin Neurosci.200325314014812904978
   PubMed Web of Science ®Google Scholar
• UebelhackR.GruenwaldJ.GraubaumHJ.BuschR.Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial. AdvTher.200421265275
   Google Scholar
• LaakmannG.Faltermaier-TernizelM.Bossert-ZaudigS.BaghaiT.Are benzodiazepines antidepressants? Psychopharmacology (Berl).19961242912928740055
   PubMed Web of Science ®Google Scholar
• KirschI.DeaconBJ.Huedo-MedinaTB.ScoboriaA.MooreTJ.JohnsonBT.Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med.20085e4518303940
   PubMed Web of Science ®Google Scholar
• SheltonRC.AndornAC.MallinckrodtCH.et al.Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression. Int Clin Psychopharrnacol.200722348355
   PubMed Web of Science ®Google Scholar
• VolzHP.LauxP.Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine. Compr Psychiatry.200041(suppl 1)13313710746915
   PubMed Web of Science ®Google Scholar
• HegerlU.Pfeiffer-GerschelT.AlthausD.[Elements for the effective treatment of patients with depressive disorders at the primary care level],MMW Fortschr Med.2004 24;146. Spec No 210 12014
   Google Scholar
• AndersonIM.Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord.200058193610760555
   PubMed Web of Science ®Google Scholar
• CiprianiA.BarbuiC.BrambillaP.FurukawaTA.HotopfM.GeddesJR.Are all antidepressants really the same? the case of fluoxetine: a systematic review. J Clin Psychiatry.20066785086416848644
   PubMed Web of Science ®Google Scholar
• AndersonIM.SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety.19987(suppl 1)11179597346
   PubMedGoogle Scholar
• Danish University Antidepressant Group. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord.1993281051168354766
   PubMed Web of Science ®Google Scholar
• MontgomerySA.BaldwinDS.BlierP.et al.Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol.20072232332917917550
   PubMed Web of Science ®Google Scholar
• KirschI.DeaconBJ.Huedo-MedinaTB.ScoboriaA.MooreTJ.JohnsonBT.Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med.20085e4518303940
   PubMed Web of Science ®Google Scholar
• SartoriusN.BaghaiTC.BaldwinDS.et al.Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol.200710(suppl 1)S1S20718096106
   PubMed Web of Science ®Google Scholar
• CoryellW.Psychotic depression. J Clin Psychiatry.199657(suppl 3)27318626367
   PubMed Web of Science ®Google Scholar
• MulsantBH.SweetRA.RosenJ.et al.A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry.20016259760411561930
   PubMed Web of Science ®Google Scholar
• RothschildAJ.SamsonJA.BessetteMP.Carter-CampbellJT.Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry.1993543383428104930
   PubMed Web of Science ®Google Scholar
• AntonRF.Jr.Burch EA, Jr. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.Am J Psychiatry.1990147120312082201223
   PubMed Web of Science ®Google Scholar
• ZanardiR.FranchiniL.GasperiniM.SmeraldiE.PerezJ.Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study, int Clin Psychopharmacol.1997121951979347379
   PubMed Web of Science ®Google Scholar
• ZanardiR.FranchiniL.GasperiniM.PerezJ.SmeraldiE.Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry.1996153163116338942464
   PubMed Web of Science ®Google Scholar
• CoryellW.The treatment of psychotic depression. J Clin Psychiatry.199859(suppl 1)22279448666
   PubMed Web of Science ®Google Scholar
• BirkenhagerTK.RenésJW.PluijmsEM.One-year follow-up after successful ECT: a naturalistic study in depressed inpatients. J Clin Psychiatry.200465879114744175
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association Committee on Electroconvulsive Therapy: Weiner RD, Coffey CE, et al. The Practice of Electroconvulsive Therapy. 2nd ed. Washington, DC: American Psychiatric Association;2001
   Google Scholar
• BauerM.AdliM.BaethgeC.et al.Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.Can J Psychiatry.20034844044812971013
   PubMed Web of Science ®Google Scholar
• PriceLH.ConwellY.NelsonJC.Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry.19831403183226131612
   PubMed Web of Science ®Google Scholar
• StarksteinSE.PetraccaG.TesonA.et al.Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry.199660326328609512
   PubMed Web of Science ®Google Scholar
• TaylorMA.FinkM.Catatonia in psychiatric classification: a home of its own. Am J Psychiatry.20031601233124112832234
   PubMed Web of Science ®Google Scholar
• FinkM.Catatonia and DSM-IV. Convuls Ther.1992815916211941165
   PubMedGoogle Scholar
• RohlandBM.CarrollBT.JacobyRG.ECT in the treatment of the catatonic syndrome. J Affect Disord.1993292552618126312
   PubMed Web of Science ®Google Scholar
• FinkM.Is catatonia a primary indication for ECT?Convuls Ther.1990614
   Google Scholar
• AkiskalH.BourgeoisML.AngstJ.PostR.MöllerH-J.HirschfeldRM.Reevaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord.200059(suppl 1530
   Web of Science ®Google Scholar
• CassanoGB.MusettiL.PerugiG.et al.A proposed new approach to the clinical subclassification of depressive illness. Pharmacopsychiatry.19882119233362961
   PubMed Web of Science ®Google Scholar
• AkiskalHSBenazziF.The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. J Affect Disord.200692455416488021
   PubMed Web of Science ®Google Scholar
• GoldbergJF.When do antidepressants worsen the course of bipolar disorder? J Psychiatr Pract.2003918119415985931
   PubMedGoogle Scholar
• AngstJ.Do many patients with depression suffer from bipolar disorder? Can J Psychiatry.2006513516491977
   PubMed Web of Science ®Google Scholar
• PattenSB.Does almost everybody suffer from a bipolar disorder? Can J Psychiatry.2006516816491978
   PubMed Web of Science ®Google Scholar
• GijsmanHJ.GeddesJR.RendellJM.NolenWA.GoodwinGM.Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry.20041611537154715337640
   PubMed Web of Science ®Google Scholar
• SachsGS.LaterB.StollAL.et al.A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry.1994553913937929019
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperS.GoodwinG.et al.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.World J Biol Psychiatry.2002311512412478876
   PubMedGoogle Scholar
• PeetMInduction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry.19941645495508038948
   PubMed Web of Science ®Google Scholar
• YathamLN.Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am.20052832534715826735
   PubMed Web of Science ®Google Scholar
• MöllerHJ.GrunzeH.BroichK.Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci.200625611616078087
   PubMed Web of Science ®Google Scholar
• ZanardiR.SmeraldiE.A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol.20061628128716316746
   PubMed Web of Science ®Google Scholar
• RoccaP.FonzoV.RavizzaL.et al.A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder. J Affect Disord.20027031331712128243
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalHS.MaserJD.et al.A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry.1998556947009707379
   PubMed Web of Science ®Google Scholar
• PezawasL.StamenkovicM.KasperS.[Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy]. Nervenarzt.20017216918011268761
   PubMed Web of Science ®Google Scholar
• MontgomeryDB.RobertsA.GreenM.BullockT.BaldwinD.MontgomerySA.Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci.19942442112157888419
   PubMed Web of Science ®Google Scholar
• AngstJ.Dobler-MikolaA.The Zurich Study-a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression. Eur Arch Psychiatry Neurol Sci.19852344084163875489
   PubMedGoogle Scholar
• PezawasL.AngstJ.KasperS.Recurrent brief depression revisited. Int Rev Psychiatry.200517637016194772
   PubMed Web of Science ®Google Scholar
• KasperS.RogersSL.MaddenPA.Joseph-VanderpoolJR.RosenthalNE.The effects of phototherapy in the general population. J Affect Disord.1990182112192139066
   PubMed Web of Science ®Google Scholar
• RosenthalNE.SackDA.CarpenterCJ.ParryBL.MendelsonWB.WehrTA.Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry19851421631703882000
   PubMed Web of Science ®Google Scholar
• Praschak-RiederN.NeumeisterA.HesselmannB.WilleitM.BarnasC.KasperS.Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J Clin Psychiatry.1997583893929378689
   PubMed Web of Science ®Google Scholar
• FountoulakisKN.lacovidesA.NimatoudisI.KaprinisG.lerodiakonouC.Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry.19991442643310683628
   PubMed Web of Science ®Google Scholar
• NovickJS.StewartJW.WisniewskiSR.et al.Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry.2005661002101116086615
   PubMed Web of Science ®Google Scholar
• HenkelV.MerglR.CoyneJC.et al.Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences. J Affect Disord.20048323724215555720
   PubMed Web of Science ®Google Scholar
• AngstJ.GammaA.BenazziF.AjdacicV.RösslerW.Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatrica Scandinavica.20071157284
   Web of Science ®Google Scholar
• SogaardJ.LaneR.LatimerP.et al.A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression . J Psychopharmacol.199913406414 10667618
   PubMed Web of Science ®Google Scholar
• AndrewsJM.NemeroffCB.Contemporary management of depression. Am J Med.199419;97 (6A)24S32S
   Web of Science ®Google Scholar
• ArmitageR.Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand.2007115104115
   Web of Science ®Google Scholar
• ThaseME.Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry.199960(suppl 17)283110446739
   PubMed Web of Science ®Google Scholar
• TranPV.BymasterFP.McNamaraRK.PotterWZ.Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol.200323788612544378
   PubMed Web of Science ®Google Scholar
• RiemannD.VoderholzerU.CohrsS.et al.Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry.20023516517412237787
   PubMed Web of Science ®Google Scholar
• LeproultR.VanOA.L'hermite-BaleriauxM.VanCE.CopinschiG.Phaseshifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf).20056329830416117817
   PubMed Web of Science ®Google Scholar
• LooH.DaleryJ.MacherJP.PayenA.[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders]. Encéphale.200228356362
   PubMed Web of Science ®Google Scholar
• LooH.DaleryJ.MacherJP.PayenA.[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders]. Encephale.20032916517114567168
   PubMed Web of Science ®Google Scholar
• FavaM.Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry.20026330530712000203
   PubMed Web of Science ®Google Scholar
• SimonGE.VonKorffM.PiccinelliM.FullertonC.OrmelJ.An international study of the relation between somatic symptoms and depression. N Engl J Med.199928;34113291335
   Web of Science ®Google Scholar
• SaartoT.WiffenPJ.Antidepressants for neuropathic pain. Cochrane Database Syst Rev.200517CD00545416034979
   PubMedGoogle Scholar
• MattiaC.PaolettiF.ColuzziF.BoanelliA.New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol.20026810511411981519
   PubMedGoogle Scholar
• BarkinRL.BarkinS.The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy. Am J Ther.20051243143816148429
   PubMedGoogle Scholar
• endreauRM.ThornMD.GendreauJF.et al.Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol.2005321975198516206355
   PubMed Web of Science ®Google Scholar
• FavaM.The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J. Clin Psychiatry.200364(suppl 13)262914552653
   PubMed Web of Science ®Google Scholar
• HameedU.SchwartzTL.MalhotraK.WestRL.BertoneF.Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression. Ann Clin Psychiatry.200517778116075660
   PubMedGoogle Scholar